MEETING ON MOLECULAR BASIS OF TUMOR IMMUNOLOGY

要求为美国科学家组织的一次科学会议提供支助， 美国癌症研究协会（AACR）。 会议题为 “肿瘤免疫学的分子基础”，并将在喜来登酒店举行 1990年5月20日至22日，弗吉尼亚州雷斯顿的雷斯顿酒店。 组委会 本次会议的委员会由德W博士组成。Mak，主席; 作者声明：John W. Vitetta首席研究员 二十 分子生物学、分子生物学和分子生物学领域的科学领导者 免疫学和肿瘤免疫学将进行演讲， 不仅能更好地了解肿瘤的演变， 发展，而且最终控制恶性细胞的生长。 大约150名其他与会者将有机会介绍 他们自己的工作在海报会议。 预计这一 分子免疫学家和肿瘤学家之间的思想交流将 产生新的方法和实验， 通过操纵免疫细胞的肿瘤进化， 他们的产品. 免疫球蛋白基因、T细胞受体基因、 抗原，MHC基因和T淋巴细胞的加工支持了 假设免疫系统及其基因可能参与了 调节肿瘤生长。 以往的科学会议 集中在上述一个或两个科学领域。 我们 这项建议的重点是免疫识别的所有分子方面 与肿瘤的发生和生长有关。 参与者将来自所有相关科学领域和所有 从研究生到高级科学家， 医生 由此产生的信息交流应产生 为实验室和临床提供有价值的新线索。

Support is requested for a scientific meeting organized by the American Association for Cancer Research, Inc. (AACR). The conference is entitled "Molecular Basis of Tumor Immunology" and will be held at the Sheraton Reston Hotel in Reston, Virginia, on May 20-22, 1990. The Organizing Committee for this conference consists of Drs. Tak W. Mak, Chairperson; Lloyd J. Old; and Ellen S. Vitetta, Principal Investigator. Twenty scientific leaders in the fields of molecular biology, molecular immunology, and tumor immunology will make presentations aimed at producing not only a better understanding of the evolution of tumor development, but also the eventual control of growth malignant cells. Approximately 150 other participants will have the opportunity to present their own work during a poster session. It is anticipated that this exchange of ideas between molecular immunologists and oncologists will produce new approaches and experiments that will lead to the containment of neoplastic evolution through manipulation of the immune cells and their products. Recent studies of immunoglobulin genes, T-cell receptor genes, the processing of antigens, MHC genes, and T-lymphocytes have supported the hypothesis that the immune system and its genes may be involved in the regulation of neoplastic growth. Previous scientific meetings have concentrated on one or two of the scientific areas described above. Our proposal is to focus on all the molecular aspects of immune recognition pertaining to neoplastic genesis and growth. Participants will be drawn from all relevant scientific areas and all levels of training, from graduate students to senior scientists or physicians. The resulting exchange of information should produce valuable new leads for both the laboratory and the clinic.